Catalent Names President of Asia Pacific

From DCAT Value Chain Insights (VCI)

By People On The Move posted 11-07-2014 18:23

Catalent Pharma Solutions has appointed Mark Bisset, currently Australia country general manager, to president, Catalent Asia Pacific. He succeeds David Heyens, who has announced that he plans to retire from Catalent on December 31, 2014.

Prior to joining Catalent, Mr. Bisset was chief executive officer for Strides Europe, leading all commercial and manufacturing activities across multiple countries while based in Poland. He had previously spent four years as chief operating officer for Strides’ Australian and Asian businesses, overseeing a number of acquisitions, including the successful integration of the ex-Genepharm business. Before that, he held global business development and product management roles with Mayne Pharma Ltd., Amrad Pharmaceuticals Pty Ltd., and Bristol Myers Squibb.

Source: Catalent Pharma Solutions

Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription